Evidence map›Paper›PMID 28130337›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2017

Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca

Carlos Enrique Guerrero-Beltrán, Judith Bernal-Ramírez, Omar Lozano, Yuriana Oropeza-Almazán, Elena Cristina Castillo, Jesús Roberto Garza, Noemí García, Jorge Vela, Alejandra García-García, Eduardo Ortega and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Myocardial SERCA2 Protects Against Cardiac Damage and Dysfunction Caused by Inhaled Bromine.The Journal of pharmacology and experimental therapeutics · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Carlos Enrique Guerrero-BeltránCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.ORCID http://orcid.org/0000-0002-5001-0093
Judith Bernal-RamírezCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Omar LozanoCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Yuriana Oropeza-AlmazánCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Elena Cristina CastilloCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Jesús Roberto GarzaCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Noemí GarcíaCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Jorge VelaCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Alejandra García-GarcíaCentro de Investigación en Materiales Avanzados S.C. Unidad Monterrey, Apodaca Nuevo León, México.ORCID http://orcid.org/0000-0001-7794-135X
Eduardo OrtegaDepartment of Physics and Astronomy, The University of Texas at San Antonio, San Antonio, Texas.
Guillermo Torre-AmioneCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México.
Nancy Ornelas-SotoLaboratorio de Nanotecnología Ambiental, Centro del Agua, Tecnológico de Monterrey, Monterrey, México.
Gerardo García-RivasCátedra de Cardiología y Medicina Vascular, Escuela Nacional de Medicina, Tecnológico de Monterrey, Monterrey, México; gdejesus@itesm.mx.ORCID http://orcid.org/0000-0003-4731-3293
Tecnológico de Monterrey · MXHospital Zambrano Hellion · MXCentro de Investigación en Materiales Avanzados · MXHouston Methodist · USThe University of Texas at San Antonio · USUniversity of Namur · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence has shown that nanoparticles that have been used to improve or create new functional properties for common products may pose potential risks to human health. Silicon dioxide (SiO

Indexed as

Adenosine TriphosphateAnimalsCalciumCardiotoxicityCell MembraneCells, CulturedDose-Response Relationship, DrugEnergy MetabolismGlutathioneMaleMembrane Potential, MitochondrialMitochondria, HeartMyocytes, CardiacNanoparticlesOxidative StressRatsAdenosine TriphosphateCalciumGlutathioneSarcoplasmic Reticulum Calcium-Transporting ATPasesSilicon DioxideCa2+cardiomyocytenanoparticlesilicon dioxidetoxicity

Identifiers

PMID28130337
PMCPMC5407167
OpenAlexW2581623971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.